805 related articles for article (PubMed ID: 19549581)
1. Management of infections complicating allogeneic hematopoietic stem cell transplantation.
Hiemenz JW
Semin Hematol; 2009 Jul; 46(3):289-312. PubMed ID: 19549581
[TBL] [Abstract][Full Text] [Related]
2. [Allogeneic hematopoietic stem-cell transplantation for hematological malignancies].
Michallet M; Dhedin N; Michallet AS
Bull Cancer; 2001 Sep; 88(9):908-26. PubMed ID: 11604365
[TBL] [Abstract][Full Text] [Related]
3. Infections in patients with multiple myeloma.
Nucci M; Anaissie E
Semin Hematol; 2009 Jul; 46(3):277-88. PubMed ID: 19549580
[TBL] [Abstract][Full Text] [Related]
4. Complications and risks in hematopoietic stem cell transplant patients.
Smith LA; Wright-Kanuth MS
Clin Lab Sci; 2001; 14(2):118-24. PubMed ID: 15625985
[TBL] [Abstract][Full Text] [Related]
5. Reduced intensity conditioning for allogeneic hematopoietic stem-cell transplant determines the kinetics of acute graft-versus-host disease.
Turner BE; Kambouris ME; Sinfield L; Lange J; Burns AM; Lourie R; Atkinson K; Hart DN; Munster DJ; Rice AM
Transplantation; 2008 Oct; 86(7):968-76. PubMed ID: 18852664
[TBL] [Abstract][Full Text] [Related]
6. Infectious complications after allogeneic stem cell transplantation: incidence in matched-related and matched-unrelated transplant settings.
Rieger CT; Rieger H; Kolb HJ; Peterson L; Huppmann S; Fiegl M; Ostermann H
Transpl Infect Dis; 2009 Jun; 11(3):220-6. PubMed ID: 19298239
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo selection of recipient-type alloantigen-specific CD4(+)CD25(+) immunoregulatory T cells for the control of graft-versus-host disease after allogeneic hematopoietic stem-cell transplantation.
Trenado A; Fisson S; Braunberger E; Klatzmann D; Salomon BL; Cohen JL
Transplantation; 2004 Jan; 77(1 Suppl):S32-4. PubMed ID: 14726768
[TBL] [Abstract][Full Text] [Related]
8. Infectious complications following unrelated cord blood transplantation.
van Burik JA; Brunstein CG
Vox Sang; 2007 May; 92(4):289-96. PubMed ID: 17456152
[TBL] [Abstract][Full Text] [Related]
9. Compromised recovery of natural interferon-alpha/beta-producing cells after allogeneic hematopoietic stem cell transplantation complicated by acute graft-versus-host disease and glucocorticoid administration.
Kitawaki T; Kadowaki N; Ishikawa T; Ichinohe T; Uchiyama T
Bone Marrow Transplant; 2003 Jul; 32(2):187-94. PubMed ID: 12838284
[TBL] [Abstract][Full Text] [Related]
10. Complications of allogeneic hematopoietic stem cell transplantation.
Arnaout K; Patel N; Jain M; El-Amm J; Amro F; Tabbara IA
Cancer Invest; 2014 Aug; 32(7):349-62. PubMed ID: 24902046
[TBL] [Abstract][Full Text] [Related]
11. Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation.
Giebel S; Nowak I; Dziaczkowska J; Czerw T; Wojnar J; Krawczyk-Kulis M; Holowiecki J; Holowiecka-Goral A; Markiewicz M; Kopera M; Karolczyk A; Kyrcz-Krzemien S; Kusnierczyk P
Eur J Haematol; 2009 Oct; 83(4):343-56. PubMed ID: 19500138
[TBL] [Abstract][Full Text] [Related]
12. Multiple viral infections post-hematopoietic stem cell transplantation are linked to the appearance of chronic GVHD among pediatric recipients of allogeneic grafts.
Olkinuora HA; Taskinen MH; Saarinen-Pihkala UM; Vettenranta KK
Pediatr Transplant; 2010 Mar; 14(2):242-8. PubMed ID: 19691523
[TBL] [Abstract][Full Text] [Related]
13. Emerging drugs for acute graft-versus-host disease.
Khaled Y; Reddy P; Krijanovski O
Expert Opin Emerg Drugs; 2009 Jun; 14(2):219-32. PubMed ID: 19519285
[TBL] [Abstract][Full Text] [Related]
14. The history and future prospective of haplo-identical stem cell transplantation.
Handgretinger R; Lang P
Cytotherapy; 2008; 10(5):443-51. PubMed ID: 18615344
[TBL] [Abstract][Full Text] [Related]
15. Nonmyeloablative and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation: a clinical review.
Pollack SM; O'Connor TP; Hashash J; Tabbara IA
Am J Clin Oncol; 2009 Dec; 32(6):618-28. PubMed ID: 19593085
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in antifungal prevention and treatment.
Groll AH; Tragiannidis A
Semin Hematol; 2009 Jul; 46(3):212-29. PubMed ID: 19549575
[TBL] [Abstract][Full Text] [Related]
17. Current concepts in allogeneic hematopoietic stem cell transplantation.
Tabbara IA; Kairouz S; Nahleh Z; Mihalcea AM
Anticancer Res; 2003; 23(6D):5055-67. PubMed ID: 14981967
[TBL] [Abstract][Full Text] [Related]
18. The role of innate immunity in graft-versus-host disease and complications following allogeneic stem cell transplant.
Holler E
Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):59-61. PubMed ID: 19147080
[No Abstract] [Full Text] [Related]
19. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
20. Managing the toxicity of hematopoietic stem cell transplant.
Pallera AM; Schwartzberg LS
J Support Oncol; 2004; 2(3):223-37; discussion 237-8, 241, 246-7. PubMed ID: 15328824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
